HALIFAX – Canadian proponents of PSA blood testing say it remains a critical diagnostic tool for prostate cancer despite criticism that it may do more harm than good. Last week, a committee of ...
News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...
SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...
A new screening tool for prostate cancer could help reduce the number of deaths from the disease, experts have said. Researchers have developed a new algorithm estimating a person’s risk of developing ...
Men checked for prostate cancer on the NHS will soon be able to get same-day results, with AI processing MRI scans in seconds. The service, set for pilot use, would see patients assessed by the bot as ...
TORONTO, June 1, 2016 /CNW/ - The Movember Foundation, the Ontario Institute for Cancer Research (OICR) and Prostate Cancer Canada today announced $3 million in funding for a new Phase III clinical ...
In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict ...
A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback